| Document |
Document Title |
|
WO/2021/218491A1 |
Provided are a nitrogen-containing compound, an electronic element, and an electronic device, and the present application belongs to the technical field of organic materials. The structure of the nitrogen-containing compound is as shown ...
|
|
WO/2021/219664A1 |
The invention relates to anti-bacterial and/or anti-viral compounds and agents as well as their uses in the treatment or prevention of bacterial and/or viral infections. The invention also provides a method for prevention, alleviation, a...
|
|
WO/2021/214073A1 |
This disclosure provides compounds of Formula (I), (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions f...
|
|
WO/2021/214243A1 |
The present invention relates to a method for preparing a compound T having a thioether group from a compound D having a disulfide group in the presence of a carbene.
|
|
WO/2021/213109A1 |
The present application belongs to the field of organic materials, and relates to an arylamine compound, an electronic component using same and an electronic device. The arylamine compound has the structure as shown in formula 1. The ary...
|
|
WO/2021/214080A1 |
The invention provides compounds of Formula (I): as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for tre...
|
|
WO/2021/208559A1 |
Disclosed in the present invention is a lead compound targeting interaction between immune nodes PD-1 and SHP-2. In a PD-1 signaling pathway of T cells, intracellular domain tyrosine residues of a membrane receptor PD-1 are phosphorylate...
|
|
WO/2021/208787A1 |
Provided is a target polypeptide used for screening drugs for treating and/or preventing cancers, wherein the target polypeptide is a polypeptide less than or equal to 200 amino acids in length, and contains an amino acid sequence that i...
|
|
WO/2021/210920A1 |
The present invention provides: a novel method for producing Ramelteon; and an intermediate compound used for the production method. The production method according to the present invention is cost-effective, and can be used to produce R...
|
|
WO/2021/210774A1 |
The present invention provides a novel compound and an organic light-emitting element comprising same.
|
|
WO/2021/210305A1 |
An organic electroluminescent element (1) comprises: a negative electrode (3); a positive electrode (4); a first light-emitting layer (51) disposed between the negative electrode (3) and the positive electrode (4) and containing a first ...
|
|
WO/2021/208951A1 |
Disclosed is a β-diketone cerium (IV) compound of formula (I). The compound has a wide absorption band, is suitable for near ultraviolet-visible region curing as a photoinitiator, and has a high sensitiveness, while also having the adva...
|
|
WO/2021/210898A1 |
The present invention provides a novel compound capable of improving light-emitting efficiency, stability, and lifespan of an element, an organic electrical element using the novel compound, and an electronic device thereof.
|
|
WO/2021/206477A1 |
The present invention provides: a novel compound which can improve the luminous efficiency, stability, and service life of an element; an organic electric element using same; and an electronic device thereof.
|
|
WO/2021/204175A1 |
Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid...
|
|
WO/2021/206478A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability, and lifespan of an element; an organic electrical element using same; and an electronic device comprising same.
|
|
WO/2021/206488A1 |
The present invention relates to an anthracene compound represented by [Formula A] and an organic light-emitting element comprising same, wherein [Formula A] is as described in the detailed description of the invention.
|
|
WO/2021/195777A1 |
The present application provides a method of treating a condition associated with coronavirus infection, the condition selected from acute respiratory distress, lung inflammation, systemic inflammation, or cytokine storm, the method comp...
|
|
WO/2021/200179A1 |
The present invention provides an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which increases in polarity by the action of an acid and (B) a compound which generates an acid upon irradiation with...
|
|
WO/2021/200876A1 |
Provided is a compound which is represented by formula (1). (Each of the symbols in the formula is as defined in the specification.) Also provided are an organic electroluminescent element that includes the compound and an electronic dev...
|
|
WO/2021/201449A1 |
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device comprising the organic electronic element. According to the present invention, an organic e...
|
|
WO/2021/200178A1 |
The present invention provides: an actinic ray-sensitive or radiation-sensitive resin composition containing (A) a resin in which polarity is increased due to acid activity, and (B) a compound which is represented by a specific general f...
|
|
WO/2021/195953A1 |
Disclosed is a method for preparing 2,5-furandicarboxylic acid. The method at least comprises: in an electrolytic cell, catalytically oxidizing an electrolytic solution with a catalyst as an anode to obtain 2,5-furandicarboxylic acid. Th...
|
|
WO/2021/202822A1 |
The present invention relates to methods of treating, delaying the onset of, slowing the progression of, or reducing the severity of age-related diseases by administering a compound of Formula 1 to a subject in need thereof. The inventio...
|
|
WO/2021/189343A1 |
A hydrate of dimethylaminomicheliolide fumarate and a preparation method therefor and use thereof. The hydrate is a crystal form D, is high in crystallinity, smooth in particle surface, free of coalescence, high in bulk density and good ...
|
|
WO/2021/193654A1 |
Provided are a compound that further improves the performance of an organic EL element, an organic electroluminescent element having improved element performance, and an electronic device including such an organic electroluminescent elem...
|
|
WO/2021/195128A1 |
The present disclosure relates to methods for ameliorating or treating an eIF4A dependent condition or disease in a subject in need thereof. The methods of the disclosure comprise administering to the subject a therapeutically effective ...
|
|
WO/2021/188855A1 |
Provided herein are compounds and methods for modulating the NFKB pathway. More particularly, provided are inhibitors of the NFkB pathway and the uses of such inhibitors in regulating diseases and disorders, e.g., to treat cancer, such a...
|
|
WO/2021/188769A1 |
Compounds that inhibit HIF-2a, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse arr...
|
|
WO/2021/186324A1 |
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; (I) a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharm...
|
|
WO/2021/182101A1 |
Provided is a compound represented by formula (1). At least one among R11-R28 and R31-R40 is not a hydrogen atom.
|
|
WO/2021/183298A1 |
A chemoenzymatic process for the preparation of 2,5-furan dicarboxylic acid includes contacting D-glucose with (i) at least two enzymes selected from the group consisting essentially of galactose oxidase, pyranose 2-oxidase, glucarate de...
|
|
WO/2021/179683A1 |
Provided is a method for preparing an eribulin intermediate, comprising the following steps: (1) reacting a compound as represented by formula (I) with (2-(R-substituted oxy)ethyl)triphenylphosphonium bromide in a tetrahydrofuran solvent...
|
|
WO/2021/177219A1 |
Provided is a catalyst which can be used for enabling a reductive amination reaction under a low-temperature low-hydrogen-pressure condition, comprises cobalt supported on an oxide, and is characterized by being produced by a method incl...
|
|
WO/2021/178468A1 |
Residual lignin recovered from biological conversion processes and pulp and paper industry wastes can be converted to water-soluble products by alkaline oxidation under oxygen pressure at high solids loading within the temperature range ...
|
|
WO/2021/178329A1 |
A method of forming an immobilized and separated Diels-Alder adduct is disclosed. This method includes a Diels-Alder reaction between a surface-supported dienophile and a furan-based diene to form an immobilized and separated Diels-Alder...
|
|
WO/2021/170464A1 |
The invention relates to compounds of formula (I), and their use as herbicides. In said formula, R1 to R9 represent groups such as hydrogen, halogen or organic groups such as alkyl, alkenyl, alkynyl, or alkoxy; X is a bond or a divalent ...
|
|
WO/2021/168988A1 |
The present invention provides a synthesis method for a fluorine-containing chiral amine compound. The synthesis method comprises: reacting an amino donor with a fluorine-containing dihydroxy ketal compound under the catalysis of transam...
|
|
WO/2021/172955A1 |
The present invention provides an intermediate useful for the synthesis of an SGLT inhibitor and a method for preparing an SGLT inhibitor using same. According to the present invention, by developing a compound of chemical formula 5 corr...
|
|
WO/2021/169028A1 |
Disclosed is a method for preparing a hierarchical pore ZSM-5 molecular sieve, comprising: (1) mixing raw materials containing a silicon source, an aluminum source, an organic amine, a template, alcohol compounds and a pore-enlarging age...
|
|
WO/2021/172452A1 |
The purpose of the present invention is: to provide an organic compound that is for use as a material for a highly efficient and durable organic EL element, that has excellent hole injection/transport performance, that has an electron-bl...
|
|
WO/2021/170864A1 |
The present invention is directed to a process for the manufacture of 1,1,4,4- tetramethoxy-2-butene from 2,5-dimethoxy-2,5-dihydrofuran with methanol in the presence of an acidic ion exchanger as catalyst, whereby the molar ratio of 2,5...
|
|
WO/2021/166702A1 |
The present invention provides a method for accomplishing a reverse-Markovnikov type Wacker oxidation reaction using a terminal alkene that has a substituent in the β-position as a starting material. The present invention specifically p...
|
|
WO/2021/168341A1 |
The present application relates to two crystalline polymorphic forms, crystalline methanol, ethanol and tetrahydrofuran solvates and a crystalline hydrate of the compound l-(5-(3-(7-(3-fluorophenyl)-3H- imidazo[4,5-c]pyridin-2-yl)-1H-pyr...
|
|
WO/2021/167511A1 |
A method and system for recovery of energy from a continuously operated steam explosion reactor (218) for production of biomass pellets or briquettes, said method comprising the steps of: - condensing a blow-steam from the steam explosio...
|
|
WO/2021/163921A1 |
Provided is a compound, which has an excellent chemical stability, a high solubility to a solvent, and exhibits an excellent carrier mobility. The compound is a compound represented by the following formula (1). [In formula (1), X1, X2, ...
|
|
WO/2021/165991A1 |
The present invention relates to 5-methyl substituted furan compounds of general formula (I) and process for the preparation thereof: OR1R2 R3CH3(I) Particularly, the present invention relates to a metal catalyst and hydrogen gas free, a...
|
|
WO/2021/166990A1 |
The present disclosure relates to a compound that makes it possible to obtain a thermoplastic resin having a high refractive index and suitable moldability without any risk of corroding a mold when used as a monomer of a thermoplastic re...
|
|
WO/2021/166552A1 |
Provided is an organic electroluminescence element including a positive electrode, a light-emitting layer, and a negative electrode in this order, the light-emitting layer containing delayed fluorescent compound M2 and compound M3 having...
|
|
WO/2021/166553A1 |
An organic electroluminescent element which includes an anode, a cathode, and a luminescent layer disposed between the anode and the cathode, wherein the luminescent layer comprises delayed fluorescent compound M2 having at least one deu...
|
